The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

BD is expanding its long-running partnership with the blood collection company Babson Diagnostics, which aims to make taking a high-quality sample in pharmacies, grocery stores or at home as easy as ...